HSK39004

DRUG2 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

Healthy DonorsHealthy Volunteers

Phase 1

Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation

CompletedNCT06905847

Haisco Pharmaceutical Group Co., Ltd.Healthy Donors

Start: 2024-09-02End: 2025-03-20Updated: 2025-04-02

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dry Powder Inhalation

CompletedNCT06971198

Haisco Pharmaceutical Group Co., Ltd.Healthy Volunteers

Start: 2025-02-10End: 2025-05-06Updated: 2025-05-14